Merck’s Deadly Vioxx Playbook, Redux: a Debunked Smear Campaign Against its Competing Drug—The FDA-approved, Nobel Prize-Honored Ivermectin

The opinions expressed in this article are solely those of the author and do not necessarily reflect the views or opinions of TrialSite Inc., its staff, or its affiliates. The information provided is based on the author's understanding and knowledge at the time of writing and is subject to change as new information becomes available. Readers are encouraged to seek diverse perspectives and perform their own research before forming their own opinion.